AstraZeneca has announced a $2.5bn investment in the company’s sixth worldwide strategic research and development (R&D) centre in Beijing, China. The initiative, which will take place up to 2029 ...

But the deal is also a much-needed win for China when investment into the world’s second-largest economy is slowing, as trade tensions shift the global focus to the US – AstraZeneca’s biggest market.

China also has a near one-third stake in the Hinkley nuclear power plant in Somerset, while Hong Kong billionaire Li Ka-shing ...

AstraZeneca announced an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance ...

(MENAFN- The Conversation) China's president Xi Jinping recently held a meeting with 40 leaders of multinational companies, including BMW and AstraZeneca ... Trump bounce and inspire businesses to ...

Foreign CEOs including Tim Cook of Apple, Cristiano Amon of Qualcomm, Pascal Soriot of AstraZeneca as well as visiting U.S. Republican Senator Steve Daines are in Beijing to attend the China ...

The pharmaceutical firm expects its workforce in Beijing to grow to 1,700 employees and is launching a JV with BioKangtai to help make vaccines; there is also investment into AI. UK and Swedish ...

AstraZeneca (AZ) has said it will be investing $2.5bn in China ... The site will be located in the Beijing International Pharmaceutical Innovation Park (BioPark) and will be enabled by an artificial ...

China's Vice Premier He Lifeng has reassured foreign business leaders that Beijing will continue to open up its market and welcome more investment from multinational companies, according to a ...

He also discussed deepening economic and trade partnerships between U.S. and China at the meeting Sunday with top executives from Apple, Pfizer, Mastercard, Eli Lilly and other multinational ...